Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 10, 2014, Pages 1713-1717

  Slekovec, C ^a,b   Robert, J ^c   Trystram, D ^c   Delarbre, J M ^d   Merens, A ^e   van der Mee Marquet, N ^f   de Gialluly, C ^f   Costa, Y ^g   Caillon, J ^h   Hocquet, D ^a,b   Bertrand, X ^a,b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CENTRE HOSPITALIER DE MULHOUSE   (France)

^e SERVICE D ENDOCRINOLOGIE   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g Centre hospitalier de Lagny Marne la Vallee   (France)

^h NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; EXTENSIVELY DRUG RESISTANT ISOLATE; FRANCE; HOSPITAL; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; WILD TYPE; CROSS INFECTION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; ENVIRONMENTAL MICROBIOLOGY; FRANCE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PSEUDOMONAS AERUGINOSA;

EID: 84911007525     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2125-8     Document Type: Article

References (23)

1. Kerr KG, Snelling AM (2009) Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 73:338–344
2. Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634–640
3. Hocquet D, Plesiat P, Dehecq B, Mariotte P, Talon D, Bertrand X (2010) Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France. Antimicrob Agents Chemother 54:3512–3515
4. Cholley P, Thouverez M, Hocquet D, van der Mee-Marquet N, Talon D, Bertrand X (2011) Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J Clin Microbiol 49:2578–2583
5. Milan O, Debroize L, Bertrand X, Plesiat P, Valentin AS, Quentin R, Van der Mee-Marquet N (2013) Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France. Antimicrob Resist Infect Control 2(1):12
6. Giske CG, Libisch B, Colinon C, Scoulica E, Pagani L, Fuzi M, Kronvall G, Rossolini GM (2006) Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol 44:4309–4315
7. Koh TH, Khoo CT, Tan TT, Arshad MA, Ang LP, Lau LJ, Hsu LY, Ooi EE (2010) Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel bla(IMP-26) gene. J Clin Microbiol 48:2563–2564
8. Edelstein MV, Skleenova EN, Shevchenko OV, D’Souza JW, Tapalski DV, Azizov IS, Sukhorukova MV, Pavlukov RA, Kozlov RS, Toleman MA, Walsh TR (2013) Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect Dis 13:867–876
9. Antimicrobial Resistance Surveillance in Europe: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2011. http://www.ecdc.europa.eu/en/publications/publications/antimicrobial-resistance-surveillance-europe-2011.pdf, Stockholm: European Centres for Disease Control
10. European Committee on Antimicrobial Susceptibility Testing (EUCAST 2013). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_31.pdf
11. Observatoire National de l’Epidémiologie de la Résistance Bactérienne aux Antibiotiques. http://www.onerba.org/
12. Comité de l’antibiogramme de la Société Française de Microbiologie. Recommandations 2012. www.sfm-microbiologie.org/UserFiles/file/CASFM/CASFM_2012.pdf
13. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281
14. Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183–190
15. Lagace-Wiens PR, Adam HJ, Low DE, Blondeau JM, Baxter MR, Denisuik AJ, Nichol KA, Walkty A, Karlowsky JA, Mulvey MR, Hoban DJ, Zhanel GG (2013) Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007–11. J Antimicrob Chemother 68 [Suppl 1]:i23–i29
16. Master RN, Clark RB, Karlowsky JA, Ramirez J, Bordon JM (2011) Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Int J Antimicrob Agents 38:291–295
17. Bertrand X, Dowzicky MJ (2012) Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther 34:124–137
18. Cavalié P (2012) Trends in antibiotic use in France in 2000–2010. Bull Epidemiol Hebd (Paris) 42–43:480–483
19. Cornaglia G, Giamarellou H, Rossolini GM (2011) Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis 11:381–393
20. Fournier D, Richardot C, Muller E, Robert-Nicoud M, Llanes C, Plesiat P, Jeannot K (2013) Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. J Antimicrob Chemother 68:1772–1780
21. Ranellou K, Kadlec K, Poulou A, Voulgari E, Vrioni G, Schwarz S, Tsakris A (2012) Detection of Pseudomonas aeruginosa isolates of the international clonal complex 11 carrying the blaPER-1 extended-spectrum beta-lactamase gene in Greece. J Antimicrob Chemother 67:357–361
22. Pournaras S, Kock R, Mossialos D, Mellmann A, Sakellaris V, Stathopoulos C, Friedrich AW, Tsakris A (2013) Detection of a phylogenetically distinct IMP-type metallo-beta-lactamase, IMP-35, in a CC235 Pseudomonas aeruginosa from the Dutch-German border region (Euregio). J Antimicrob Chemother 68:1271–1276
23. Santella G, Pollini S, Docquier JD, Mereuta AI, Gutkind G, Rossolini GM, Radice M (2010) Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621. J Clin Microbiol 48:4342–4343